Compugen is a privately owned and operated IT company, headquartered in Richmond Hill, a suburb of Toronto, Ontario, Canada. Founded and incorporated in 1981, Compugen took over first place in CDN's Top 100 Solution Providers rankings for 2011.
Compugen's lines of business include IT infrastructure products and services, and its customers include medium- and large-sized corporations and government departments. As of May 2012, Compugen employed over 1000 staff in offices across Canada and provided national coverage for on-site and managed services customers.
Compugen's head office, PC - Integration Centre, warehouse and logistics centre and service desk are located in Richmond Hill, Ontario.
Industry Awards
Zarek Named For Global Award By VMware
Compugen First Canadian Microsoft Authorized Refurbisher
Frontier college Grants Compugen Fitzpatrick Award
2011 Rated number 1 in CDN's Top 100 Solution Providers rankings
2009 Microsoft Partner of the Year for Advanced Infrastructure Solutions, Windows Desktop Deployment
Compugen operates in two areas of the biotechnology industry: it develops and markets bioinformatics software platforms and engages in in silico drug discovery. Over the years it has partnered with companies the likes of Pfizer, Novartis, Abbott, BioLineRx, and Seattle Genetics.Amgen and Bayer are among Compugen's competitors.
History
Compugen was founded in 1993 by Eli Mintz, Simchon Faigler and Amir Natan. Mintz conceived of the idea for the company in 1991 while accompanying his wife, Liat Mintz, to a genomics engagement at the Pasteur Institute in France. She commented that the quantities of data being produced by scientists involved in DNA sequencing exceeded what computers could process at reasonable speeds. Eli Mintz partnered with colleagues Faigler and Natan from the IDF's elite Talpiot program to develop a more powerful computer; and indeed, the company's first computer, dubbed the "Bioccelerator," boasted speeds up to one thousand times faster than other platforms being used at the time. In 1997, the company followed this success by introducing LEADS, an EST clustering and assembly platform. By around 2001, Compugen had effected a shift in its business model from a company whose almost exclusive focus was marketing computer programs and applications to one whose operations extended into the diagnostics and therapeutics fields.
Compugen is a therapeutic discovery and development company utilizing its broadly applicable predictive discovery infrastructure to identify novel drug targets and develop first-in-class therapeutics in the field of cancer immunotherapy. The Company’s therapeutic pipeline consists of immuno-oncology programs against novel drug targets it has discovered, including T cell immune checkpoints and myeloid target programs. The Company is headquartered in Israel, with R&D facilities in both Israel and South San Francisco, CA. Compugen’s shares are listed on NASDAQ and the Tel Aviv Stock Exchange under the ticker symbol CGEN.
Video produced by Kiklop Productions
published: 21 Nov 2017
Compugen says it is pioneering a 'computational discovery approach' to cancer immunotherapy
Compugen Ltd CEO Anat Cohen-Dayag tells Proactive's Stephen Gunnion about the drug discovery and development company focused on cancer immunotherapy using the predictive power of its unique computational discovery approach.
Cohen-Dayag explains that Compugen is advancing new therapeutics and optimizing their combination to expand immuno-oncology treatment options to cancer patients who are refractory or unresponsive to currently available drugs.
"There is great potential for a company that brings first-in-class drug opportunities to treat patients, however when you are pioneering the field, the burden of proof is on you and that is challenging," she says.
#ProactiveInvestors #Compugen #CancerImmunotherapy #ComputationalDiscovery #DrugDiscovery #DinhamAxis #NewTreatmentSolutions #Pioneer...
published: 04 May 2023
Compugen Finance provides high quality refurbished products to the education sector.
Through the awarding winning Green4Good IT asset management program, Compugen Finance offers high quality refurbished products to the education sector across North America. Every product has to pass our stringent refurbishment process. For more information, please visit us at www.compugen.com/edu
published: 26 Jan 2015
Life at Compugen
Staff members from Compugen speak about working within the Compugen environment.
published: 11 Sep 2015
Compugen DeviceValet
Compugen DeviceValet provides an improved customer experience by converting the value of Apple iPhones into a hassle-free valet service for your staff. This includes a simple, yet comprehensive Apple procurement services and set up, replacement program and online portal tracking. All while reducing expenses and earning carbon credits.
Interested in learning more about DeviceValet and how it can benefit your organization? Contact us at http://compugen.com/en/contact/.
published: 09 Oct 2019
Compugen
published: 02 Aug 2012
Compugen and the Global IT Alliance
We’re proud to partner with amazing global organizations through the Global IT Alliance.
Thank you to the Global IT Alliance for recognizing our impact in the IT sector, and our accomplishments and capabilities in helping organizations realize new possibilities through technology.
Learn more about our partnership:
#informationtechnology
published: 16 Dec 2021
Compugen Print Motion Graphic Explainer Video [Illustrate iT Video]
Explainer video by Illustrate iT Video. To see more of our animated videos go to http://www.illustrateitvideo.com
CHECK OUT MORE OF OUR WORK
http://www.youtube.com/user/illustrateit
LET'S SOCIALIZE
https://www.facebook.com/illustrateitvideo
https://www.twitter.com/illustrateit
https://www.linkedin.com/company/illustrate-it-inc.
https://www.pinterest.com/illustrateit
PREVENT MISUNDERSTANDINGS...ILLUSTRATE IT
http://www.illustrateitvideo.com
Compugen is a therapeutic discovery and development company utilizing its broadly applicable predictive discovery infrastructure to identify novel drug targets ...
Compugen is a therapeutic discovery and development company utilizing its broadly applicable predictive discovery infrastructure to identify novel drug targets and develop first-in-class therapeutics in the field of cancer immunotherapy. The Company’s therapeutic pipeline consists of immuno-oncology programs against novel drug targets it has discovered, including T cell immune checkpoints and myeloid target programs. The Company is headquartered in Israel, with R&D facilities in both Israel and South San Francisco, CA. Compugen’s shares are listed on NASDAQ and the Tel Aviv Stock Exchange under the ticker symbol CGEN.
Video produced by Kiklop Productions
Compugen is a therapeutic discovery and development company utilizing its broadly applicable predictive discovery infrastructure to identify novel drug targets and develop first-in-class therapeutics in the field of cancer immunotherapy. The Company’s therapeutic pipeline consists of immuno-oncology programs against novel drug targets it has discovered, including T cell immune checkpoints and myeloid target programs. The Company is headquartered in Israel, with R&D facilities in both Israel and South San Francisco, CA. Compugen’s shares are listed on NASDAQ and the Tel Aviv Stock Exchange under the ticker symbol CGEN.
Video produced by Kiklop Productions
Compugen Ltd CEO Anat Cohen-Dayag tells Proactive's Stephen Gunnion about the drug discovery and development company focused on cancer immunotherapy using the p...
Compugen Ltd CEO Anat Cohen-Dayag tells Proactive's Stephen Gunnion about the drug discovery and development company focused on cancer immunotherapy using the predictive power of its unique computational discovery approach.
Cohen-Dayag explains that Compugen is advancing new therapeutics and optimizing their combination to expand immuno-oncology treatment options to cancer patients who are refractory or unresponsive to currently available drugs.
"There is great potential for a company that brings first-in-class drug opportunities to treat patients, however when you are pioneering the field, the burden of proof is on you and that is challenging," she says.
#ProactiveInvestors #Compugen #CancerImmunotherapy #ComputationalDiscovery #DrugDiscovery #DinhamAxis #NewTreatmentSolutions #PioneersInMedicine #ClinicalStudies #OvarianCancer #ColorectalCancer #MedicalResearch #HealthcareInnovation #CancerTreatment #PrecisionMedicine #PatientCare #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
Compugen Ltd CEO Anat Cohen-Dayag tells Proactive's Stephen Gunnion about the drug discovery and development company focused on cancer immunotherapy using the predictive power of its unique computational discovery approach.
Cohen-Dayag explains that Compugen is advancing new therapeutics and optimizing their combination to expand immuno-oncology treatment options to cancer patients who are refractory or unresponsive to currently available drugs.
"There is great potential for a company that brings first-in-class drug opportunities to treat patients, however when you are pioneering the field, the burden of proof is on you and that is challenging," she says.
#ProactiveInvestors #Compugen #CancerImmunotherapy #ComputationalDiscovery #DrugDiscovery #DinhamAxis #NewTreatmentSolutions #PioneersInMedicine #ClinicalStudies #OvarianCancer #ColorectalCancer #MedicalResearch #HealthcareInnovation #CancerTreatment #PrecisionMedicine #PatientCare #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
Through the awarding winning Green4Good IT asset management program, Compugen Finance offers high quality refurbished products to the education sector across No...
Through the awarding winning Green4Good IT asset management program, Compugen Finance offers high quality refurbished products to the education sector across North America. Every product has to pass our stringent refurbishment process. For more information, please visit us at www.compugen.com/edu
Through the awarding winning Green4Good IT asset management program, Compugen Finance offers high quality refurbished products to the education sector across North America. Every product has to pass our stringent refurbishment process. For more information, please visit us at www.compugen.com/edu
Compugen DeviceValet provides an improved customer experience by converting the value of Apple iPhones into a hassle-free valet service for your staff. This inc...
Compugen DeviceValet provides an improved customer experience by converting the value of Apple iPhones into a hassle-free valet service for your staff. This includes a simple, yet comprehensive Apple procurement services and set up, replacement program and online portal tracking. All while reducing expenses and earning carbon credits.
Interested in learning more about DeviceValet and how it can benefit your organization? Contact us at http://compugen.com/en/contact/.
Compugen DeviceValet provides an improved customer experience by converting the value of Apple iPhones into a hassle-free valet service for your staff. This includes a simple, yet comprehensive Apple procurement services and set up, replacement program and online portal tracking. All while reducing expenses and earning carbon credits.
Interested in learning more about DeviceValet and how it can benefit your organization? Contact us at http://compugen.com/en/contact/.
We’re proud to partner with amazing global organizations through the Global IT Alliance.
Thank you to the Global IT Alliance for recognizing our impact in the...
We’re proud to partner with amazing global organizations through the Global IT Alliance.
Thank you to the Global IT Alliance for recognizing our impact in the IT sector, and our accomplishments and capabilities in helping organizations realize new possibilities through technology.
Learn more about our partnership:
#informationtechnology
We’re proud to partner with amazing global organizations through the Global IT Alliance.
Thank you to the Global IT Alliance for recognizing our impact in the IT sector, and our accomplishments and capabilities in helping organizations realize new possibilities through technology.
Learn more about our partnership:
#informationtechnology
Explainer video by Illustrate iT Video. To see more of our animated videos go to http://www.illustrateitvideo.com
CHECK OUT MORE OF OUR WORK
http://www.youtub...
Explainer video by Illustrate iT Video. To see more of our animated videos go to http://www.illustrateitvideo.com
CHECK OUT MORE OF OUR WORK
http://www.youtube.com/user/illustrateit
LET'S SOCIALIZE
https://www.facebook.com/illustrateitvideo
https://www.twitter.com/illustrateit
https://www.linkedin.com/company/illustrate-it-inc.
https://www.pinterest.com/illustrateit
PREVENT MISUNDERSTANDINGS...ILLUSTRATE IT
http://www.illustrateitvideo.com
Explainer video by Illustrate iT Video. To see more of our animated videos go to http://www.illustrateitvideo.com
CHECK OUT MORE OF OUR WORK
http://www.youtube.com/user/illustrateit
LET'S SOCIALIZE
https://www.facebook.com/illustrateitvideo
https://www.twitter.com/illustrateit
https://www.linkedin.com/company/illustrate-it-inc.
https://www.pinterest.com/illustrateit
PREVENT MISUNDERSTANDINGS...ILLUSTRATE IT
http://www.illustrateitvideo.com
Compugen is a therapeutic discovery and development company utilizing its broadly applicable predictive discovery infrastructure to identify novel drug targets and develop first-in-class therapeutics in the field of cancer immunotherapy. The Company’s therapeutic pipeline consists of immuno-oncology programs against novel drug targets it has discovered, including T cell immune checkpoints and myeloid target programs. The Company is headquartered in Israel, with R&D facilities in both Israel and South San Francisco, CA. Compugen’s shares are listed on NASDAQ and the Tel Aviv Stock Exchange under the ticker symbol CGEN.
Video produced by Kiklop Productions
Compugen Ltd CEO Anat Cohen-Dayag tells Proactive's Stephen Gunnion about the drug discovery and development company focused on cancer immunotherapy using the predictive power of its unique computational discovery approach.
Cohen-Dayag explains that Compugen is advancing new therapeutics and optimizing their combination to expand immuno-oncology treatment options to cancer patients who are refractory or unresponsive to currently available drugs.
"There is great potential for a company that brings first-in-class drug opportunities to treat patients, however when you are pioneering the field, the burden of proof is on you and that is challenging," she says.
#ProactiveInvestors #Compugen #CancerImmunotherapy #ComputationalDiscovery #DrugDiscovery #DinhamAxis #NewTreatmentSolutions #PioneersInMedicine #ClinicalStudies #OvarianCancer #ColorectalCancer #MedicalResearch #HealthcareInnovation #CancerTreatment #PrecisionMedicine #PatientCare #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
Through the awarding winning Green4Good IT asset management program, Compugen Finance offers high quality refurbished products to the education sector across North America. Every product has to pass our stringent refurbishment process. For more information, please visit us at www.compugen.com/edu
Compugen DeviceValet provides an improved customer experience by converting the value of Apple iPhones into a hassle-free valet service for your staff. This includes a simple, yet comprehensive Apple procurement services and set up, replacement program and online portal tracking. All while reducing expenses and earning carbon credits.
Interested in learning more about DeviceValet and how it can benefit your organization? Contact us at http://compugen.com/en/contact/.
We’re proud to partner with amazing global organizations through the Global IT Alliance.
Thank you to the Global IT Alliance for recognizing our impact in the IT sector, and our accomplishments and capabilities in helping organizations realize new possibilities through technology.
Learn more about our partnership:
#informationtechnology
Explainer video by Illustrate iT Video. To see more of our animated videos go to http://www.illustrateitvideo.com
CHECK OUT MORE OF OUR WORK
http://www.youtube.com/user/illustrateit
LET'S SOCIALIZE
https://www.facebook.com/illustrateitvideo
https://www.twitter.com/illustrateit
https://www.linkedin.com/company/illustrate-it-inc.
https://www.pinterest.com/illustrateit
PREVENT MISUNDERSTANDINGS...ILLUSTRATE IT
http://www.illustrateitvideo.com
About Compugen Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery platform (Unigen™) to identify new ...
) Compugen Reports ThirdQuarter 2024 Results... HOLON, ISRAEL - November 12, 2024 - Compugen Ltd ... Compugen expects that its cash and cash related balances will be sufficient to fund its current operating plans into 2027 ... About Compugen ... COMPUGEN LTD.
12, 2024 /PRNewswire/ -- CompugenLtd. (Nasdaq... Compugen expects that its cash and cash related balances will be sufficient to fund its current operating plans into 2027 ... About Compugen ... COMPUGEN LTD ... COMPUGEN LTD ... SOURCE Compugen Ltd.
TORONTO, Nov. 4, 2024 /PRNewswire/ -- CompugenInc., the nation's largest privately-owned and operated TechnologyAlly, is proud to announce the acquisition of SynerSolutions Technologies Inc., a leader in cybersecurity services for defence ....
Compugen to Present Anti-Tumor ... HOLON, ISRAEL, November 5, 2024 - Compugen Ltd ... The abstract is now available on the publication section of Compugen's website ... About Compugen ... Compugen has two proprietary product candidates in Phase 1 development.
COMPUGEN LTD...CompugenLtd. On November 5, 2024, Compugen Ltd ... COMPUGEN LTD ... Compugen to Present Anti-Tumor ... HOLON, ISRAEL, November 5, 2024 - Compugen Ltd ... The abstract is now available on the publication section of Compugen's website ... About Compugen.
About Compugen Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery platform (UnigenTM) to ...
Compugen to ReleaseThirdQuarter 2024 Financial Results on ... HOLON, ISRAEL, October 29, 2024 - Compugen Ltd.(Nasdaq ... The call will be available via live webcast through Compugen's website, located at the following link ... About Compugen ... Compugen Ltd.